|
|
.
See Category: Diseases of the genitourinary system
See Header: Fibroadenosis of breast
ICD-10 (CM) Code and Descriptor
|
N60.22 |
Fibroadenosis of left breast
|
N6022 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 22.92%
|
27.11%
|
25.04%
|
13.65%
|
5.05%
|
2.69%
|
1.21%
|
0.72%
|
0.51%
|
0.35%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for N60.22*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,048
|
1,254
|
|
77065
|
DX MAMMO INCL CAD UNI |
582
|
583
|
|
19081
|
BX BREAST 1ST LESION STRTCTC |
562
|
562
|
|
A4648
|
IMPLANTABLE TISSUE MARKER |
541
|
598
|
|
19083
|
BX BREAST 1ST LESION US IMAG |
332
|
332
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
265
|
308
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
218
|
419
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
216
|
216
|
|
J3010
|
FENTANYL CITRATE INJECTION |
206
|
296
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
189
|
4,931
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
185
|
230
|
|
J2405
|
ONDANSETRON HCL INJECTION |
185
|
780
|
|
76098
|
X-RAY EXAM SURGICAL SPECIMEN |
161
|
174
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
155
|
568
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
150
|
551
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
145
|
979
|
|
77066
|
DX MAMMO INCL CAD BI |
135
|
135
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
121
|
262
|
|
J2001
|
LIDOCAINE INJECTION |
111
|
1,364
|
|
19125
|
EXCISION BREAST LESION |
106
|
106
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
N60.22 related to the following DRG Codes:
600-601
|
